Yongkun Sun Selected Research

Yongkun Sun Research Topics

Disease

14	Neoplasms (Cancer) 03/2022 - 05/2014
8	Stomach Neoplasms (Stomach Cancer) 03/2022 - 05/2014
4	Hypertension (High Blood Pressure) 05/2022 - 10/2016
4	Disease Progression 09/2021 - 06/2015
3	Colorectal Neoplasms (Colorectal Cancer) 10/2021 - 06/2019
3	Adenocarcinoma 10/2018 - 06/2015
2	Biliary Tract Neoplasms (Biliary Tract Cancer) 05/2022 - 01/2021
2	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 06/2021
2	Neoplasm Metastasis (Metastasis) 10/2021 - 06/2020
2	Colonic Neoplasms (Colon Cancer) 01/2021 - 10/2016
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 10/2016
2	Proteinuria 01/2020 - 11/2018
2	Sarcoma (Soft Tissue Sarcoma) 11/2018 - 10/2016
2	Renal Cell Carcinoma (Grawitz Tumor) 06/2016 - 01/2016
2	Fetal Nutrition Disorders (Fetal Malnutrition) 09/2013 - 01/2013
1	Esophageal Squamous Cell Carcinoma 01/2022
1	DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes) 01/2021
1	Inflammation (Inflammations) 01/2019
1	Lymphoma (Lymphomas) 01/2019
1	Hand-Foot Syndrome 11/2018
1	Fatigue 11/2018
1	medullary Thyroid cancer 11/2018
1	Pneumothorax 11/2018
1	Hypertriglyceridemia 11/2018
1	Pancreatic Neoplasms (Pancreatic Cancer) 10/2018
1	Thyroid Neoplasms (Thyroid Cancer) 10/2016
1	Hyperlipidemias (Hyperlipidemia) 06/2016
1	Hypercalcemia (Milk Alkali Syndrome) 01/2016
1	Anemia 01/2016
1	Body Weight (Weight, Body) 01/2013

Drug/Important Bio-Agent (IBA)

8	anlotinibIBA 05/2022 - 10/2016
5	Oxaliplatin (Eloxatin)FDA LinkGeneric 03/2022 - 06/2015
4	Tyrosine Kinase InhibitorsIBA 05/2022 - 05/2014
3	Biomarkers (Surrogate Marker)IBA 05/2022 - 01/2020
3	Phosphotransferases (Kinase)IBA 09/2021 - 01/2019
3	Triglycerides (Triacylglycerol)IBA 11/2018 - 01/2013
2	tyrosine receptor (receptor, tyrosine)IBA 09/2021 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 05/2014
2	LipidsIBA 06/2016 - 01/2013
2	ErbB Receptors (EGF Receptor)IBA 06/2015 - 05/2014
1	B7-H1 AntigenIBA 05/2022
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 05/2022
1	Alanine Transaminase (SGPT)IBA 05/2022
1	sintilimabIBA 01/2022
1	Biosimilar PharmaceuticalsIBA 01/2022
1	Bevacizumab (Avastin)FDA Link 01/2022
1	Deubiquitinating EnzymesIBA 01/2022
1	RNA Splicing FactorsIBA 01/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2021
1	CytokinesIBA 06/2021
1	HMPL-013IBA 01/2021
1	XELOXIBA 06/2020
1	Capecitabine (Xeloda)FDA Link 06/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	dimethylarginineIBA 01/2020
1	N- methyl- N- 2- (methylsulfinyl)ethylpropionic acid amide (NMPA)IBA 01/2020
1	chiauranibIBA 01/2019
1	Aurora Kinase BIBA 01/2019
1	Angiogenesis InhibitorsIBA 11/2018
1	CholesterolIBA 11/2018
1	130-nm albumin-bound paclitaxelIBA 10/2018
1	Lipase (Acid Lipase)FDA Link 10/2016
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 06/2016
1	lactate dehydrogenase 1 (LDH1)IBA 01/2016
1	Cisplatin (Platino)FDA LinkGeneric 06/2015
1	Fluorouracil (Carac)FDA LinkGeneric 06/2015
1	Leucovorin (Folinic Acid)FDA Link 06/2015
1	Sorafenib (BAY 43-9006)FDA Link 06/2015
1	nimotuzumabIBA 06/2015
1	TeaIBA 09/2013
1	PolyphenolsIBA 01/2013
1	Adenosine Monophosphate (AMP)IBA 01/2013
1	Protein Kinases (Protein Kinase)IBA 01/2013
1	Sterol Regulatory Element Binding Protein 1IBA 01/2013

Therapy/Procedure

6	Therapeutics 03/2022 - 10/2018
6	Drug Therapy (Chemotherapy) 03/2022 - 06/2015
2	Adjuvant Chemotherapy 01/2021 - 05/2018
2	Neoadjuvant Therapy 09/2017 - 03/2017
1	Oral Administration 09/2021
1	Immunotherapy 09/2021
1	Gastrectomy 06/2020
1	Combination Drug Therapy (Combination Chemotherapy) 06/2015